EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer
Yardley, Denise A, Weaver, Robert, Melisko, Michelle E, Saleh, Mansoor N, Arena, Francis P, Forero, Andres, Cigler, Tessa, Stopeck, Alison, Citrin, Dennis, Oliff, Ira, Bechhold, Rebecca, Loutfi, Randa, Garcia, Agustin A, Cruickshank, Scott, Crowley, Elizabeth, Green, Jennifer, Hawthorne, Thomas, Yellin, Michael J, Davis, Thomas A, Vahdat, Linda T
Published in Journal of clinical oncology (10.05.2015)
Published in Journal of clinical oncology (10.05.2015)
Get full text
Journal Article
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
ATTIA, Peter, PHAN, Giao Q, RESTIFO, Nicholas P, HAWORTH, Leah R, LEVY, Catherine, MAVROUKAKIS, Sharon A, NICHOL, Geoff, YELLIN, Michael J, ROSENBERG, Steven A, MAKER, Ajay V, ROBINSON, Michael R, QUEZADO, Martha M, YANG, James C, SHERRY, Richard M, TOPALIAN, Suzanne L, KAMMULA, Udai S, ROYAL, Richard E
Published in Journal of clinical oncology (01.09.2005)
Published in Journal of clinical oncology (01.09.2005)
Get full text
Journal Article
A Phase I Trial of Atezolizumab and Varlilumab in Combination With Radiation in Patients With Metastatic NSCLC
Malhotra, Jyoti, Lin, Yong, Patel, Malini, Yellin, Michael J., Zachariah, Emmanuel, Krier, Curtis, Saxena, Ankit, Jabbour, Salma K.
Published in JTO clinical and research reports (01.08.2024)
Published in JTO clinical and research reports (01.08.2024)
Get full text
Journal Article
Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
Reardon, David A, Desjardins, Annick, Vredenburgh, James J, O'Rourke, Donald M, Tran, David D, Fink, Karen L, Nabors, Louis B, Li, Gordon, Bota, Daniela A, Lukas, Rimas V, Ashby, Lynn S, Duic, J Paul, Mrugala, Maciej M, Cruickshank, Scott, Vitale, Laura, He, Yi, Green, Jennifer A, Yellin, Michael J, Turner, Christopher D, Keler, Tibor, Davis, Thomas A, Sampson, John H
Published in Clinical cancer research (01.04.2020)
Published in Clinical cancer research (01.04.2020)
Get full text
Journal Article
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. Stephen, O'Day, Steven J, McDermott, David F, Weber, Robert W, Weber, Jeffrey S, Sosman, Jeffrey A, Haanen, John B, Gonzalez, Rene, Robert, Caroline, Schadendorf, Dirk, Hassel, Jessica C, Akerley, Wallace, van den Eertwegh, Alfons J.M, Lutzky, Jose, Lorigan, Paul, Vaubel, Julia M, Linette, Gerald P, Hogg, David, Ottensmeier, Christian H, Lebbé, Celeste, Peschel, Christian, Quirt, Ian, Clark, Joseph I, Wolchok, Jedd D, Tian, Jason, Yellin, Michael J, Nichol, Geoffrey M, Hoos, Axel, Urba, Walter J
Published in The New England journal of medicine (19.08.2010)
Published in The New England journal of medicine (19.08.2010)
Get full text
Journal Article
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors
Burris, Howard A, Infante, Jeffrey R, Ansell, Stephen M, Nemunaitis, John J, Weiss, Geoffrey R, Villalobos, Victor M, Sikic, Branimir I, Taylor, Matthew H, Northfelt, Donald W, Carson, 3rd, William E, Hawthorne, Thomas R, Davis, Thomas A, Yellin, Michael J, Keler, Tibor, Bullock, Timothy
Published in Journal of clinical oncology (20.06.2017)
Published in Journal of clinical oncology (20.06.2017)
Get full text
Journal Article
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
Hersh, Evan M., O’Day, Steven J., Powderly, John, Khan, Khuda D., Pavlick, Anna C., Cranmer, Lee D., Samlowski, Wolfram E., Nichol, Geoffrey M., Yellin, Michael J., Weber, Jeffrey S.
Published in Investigational new drugs (01.06.2011)
Published in Investigational new drugs (01.06.2011)
Get full text
Journal Article
CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression
Miller, Debra L., Yaron, Renat, Yellin, Michael J.
Published in Journal of leukocyte biology (01.03.1998)
Published in Journal of leukocyte biology (01.03.1998)
Get full text
Journal Article
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies
Ansell, Stephen M., Flinn, Ian, Taylor, Matthew H., Sikic, Branimir I., Brody, Joshua, Nemunaitis, John, Feldman, Andrew, Hawthorne, Thomas R., Rawls, Tracey, Keler, Tibor, Yellin, Michael J.
Published in Blood advances (12.05.2020)
Published in Blood advances (12.05.2020)
Get full text
Journal Article
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets
Bhardwaj, Nina, Friedlander, Philip A, Pavlick, Anna C, Ernstoff, Marc S, Gastman, Brian R, Hanks, Brent A, Curti, Brendan D, Albertini, Mark R, Luke, Jason J, Blazquez, Ana B, Balan, Sreekumar, Bedognetti, Davide, Beechem, Joseph M, Crocker, Andrea S, D'Amico, Leonard, Danaher, Patrick, Davis, Thomas A, Hawthorne, Thomas, Hess, Bruce W, Keler, Tibor, Lundgren, Lisa, Morishima, Chihiro, Ramchurren, Nirasha, Rinchai, Darawan, Salazar, Andres M, Salim, Bob A, Sharon, Elad, Vitale, Laura A, Wang, Ena, Warren, Sarah, Yellin, Michael J, Disis, Mary L, Cheever, Martin A, Fling, Steven P
Published in Nature cancer (01.12.2020)
Published in Nature cancer (01.12.2020)
Get more information
Journal Article
Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation
Yellin, Michael J., Winikoff, Stephen, Fortune, Sarah M., Baum, David, Crow, Mary K., Lederman, Seth, Chess, Leonard
Published in Journal of leukocyte biology (01.08.1995)
Published in Journal of leukocyte biology (01.08.1995)
Get full text
Journal Article
602 A phase I trial of atezolizumab and varlilumab in combination with radiation in patients with metastatic non-small cell lung cancer (NSCLC)
Malhotra, Jyoti, Lin, Yong, Patel, Malini, Yellin, Michael J, Zachariah, Emmanuel, Krier, Curtis, Saxena, Ankit, Jabbour, Salma K
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited – Authors' reply
Weller, Michael, Butowski, Nicholas, Tran, David D, Recht, Lawrence D, Lim, Michael, Hirte, Hal, Ashby, Lynn, Mechtler, Laszlo, Goldlust, Samuel A, Iwamoto, Fabio, Drappatz, Jan, O'Rourke, Donald M, Wong, Mark, Hamilton, Mark G, Finocchiaro, Gaetano, Perry, James, Wick, Wolfgang, Green, Jennifer, He, Yi, Turner, Christopher D, Yellin, Michael J, Keler, Tibor, Davis, Thomas A, Stupp, Roger, Sampson, John H
Published in The lancet oncology (01.12.2017)
Published in The lancet oncology (01.12.2017)
Get full text
Journal Article
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma
Maker, Ajay V, Yang, James C, Sherry, Richard M, Topalian, Suzanne L, Kammula, Udai S, Royal, Richard E, Hughes, Marybeth, Yellin, Michael J, Haworth, Leah R, Levy, Catherine, Allen, Tamika, Mavroukakis, Sharon A, Attia, Peter, Rosenberg, Steven A
Published in Journal of immunotherapy (1997) (01.07.2006)
Published in Journal of immunotherapy (1997) (01.07.2006)
Get more information
Journal Article
1522 Revitalizing systemic immune responses in progressive NSCLC using FLT3L and SBRT
Mathew, Divij, Ohri, Nitin, Ngiow, Shin Foong, Wumesh, KC, Halmos, Balazs, Garg, Madhur, Levsky, Jeffrey M, Cheng, Haiying, Gucalp, Rasim, Bodner, William, Kabarriti, Rafi, Gutierrez-Chavez, Claudia, Zakharia, Adel, Kalnicki, Shalom, Yellin, Michael J, Keler, Tibor, Giles, Josephine R, Guha, Chandan, John Wherry, E
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Abstract CT005: FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer
Ohri, Nitin, Halmos, Balazs, Cheng, Haiying, Abraham, Tony, Yahya, Tahir, Garg, Madhur, Bodner, William, Kabarriti, Rafi, Kalnicki, Shalom, Yellin, Michael J., Keler, Tibor, Guha, Chandan
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
Human Vascular Endothelial Cells Are a Rich and Regulatable Source of Secretory Sphingomyelinase
Marathe, Sudhir, Schissel, Scott L., Yellin, Michael J., Beatini, Nanda, Mintzer, Robert, Williams, Kevin Jon, Tabas, Ira
Published in The Journal of biological chemistry (01.02.1998)
Published in The Journal of biological chemistry (01.02.1998)
Get full text
Journal Article
IMCT-08ReACT: LONG-TERM SURVIVAL FROM A RANDOMIZED PHASE II STUDY OF RINDOPEPIMUT (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
Reardon, David A., Desjardins, Annick, Schuster, James, Tran, David D., Fink, Karen L., Nabors, Louis B., Li, Gordon, Bota, Daniela A., Lukas, Rimas V., Ashby, Lynn S., Duic, J. Paul, Mrugala, Maciej M., Werner, Andrea, Vitale, Laura, He, Yi, Green, Jennifer, Yellin, Michael J., Turner, Christopher D., Davis, Thomas A., Sampson, John H.
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2015)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2015)
Get full text
Journal Article